Related Experiment Video
Updated: Jul 25, 2026

Synthesis and Characterization of an Aspirin-fumarate Prodrug that Inhibits NFκB Activity and Breast Cancer Stem Cells
Published on: January 18, 2017
N-substituted benzamides inhibit nuclear factor-kappaB and nuclear factor of activated T cells activity while
H Lindgren1, R W Pero, F Ivars
1Department of Cell and Molecular Biology, Section for Immunology, BMC I:13, Lund University, S-221 84, Lund, Sweden. hanna.lindgren@immuno.lu.se
Abstract:
N-substituted benzamides are compounds that have recently been reported to inhibit nuclear factor-kappaB (NF-kappaB) activity and induce apoptosis in a pre-B cell line. In this study, we focused on the effects of N-substituted benzamides on transcriptional regulation in Jurkat T cells. We used a model system where the cells can be stimulated either through TCR/CD28 or by treatment of the cells with PMA and ionomycin to induce transcription factors typical for T lymphocyte activation. Treatment of the Jurkat cells with procainamide did not influence the transcription factor profile of stimulated cells, while treatment with a derivative having an acetyl group in position 4 of the aromatic ring inhibited NF-kappaB and nuclear factor of activated T cells (NFAT) activity. Declopramide, which contains a chloride in position 3 of the aromatic ring, was inactive in this system, whereas also the acetylated derivative of this compound inhibited NF-kappaB and NFAT activity. In contrast, the transcriptional activity and nuclear expression of activator protein 1 induced by TCR/CD28 stimulation or PMA and ionomycin treatment was enhanced by the acetylated variants of the N-substituted benzamides. Finally, we investigated the effect of N-substituted benzamides on intact promoters for two genes central in immune regulation; the CD40 ligand (CD40L) and IL-2 promoters. The transcriptional activity of the CD40L promoter as well as surface expression of the CD40L induced by signaling through TCR/CD28 was inhibited by addition of acetylated N-substituted benzamides, while the transcriptional activity of the IL-2 promoter was enhanced. Taken together, these data indicate that derivatives of N-substituted benzamides are potential drug candidates for quantitative as well as qualitative modulation of immune functions.
Insights
Modified N-substituted benzamides can modulate immune responses by inhibiting or enhancing specific transcription factors. These compounds show potential as drug candidates for immune regulation.
Area of Science:
- Immunology
- Molecular Biology
- Pharmacology
Background:
- N-substituted benzamides have shown potential in inhibiting nuclear factor-kappaB (NF-kappaB) and inducing apoptosis.
- Understanding their effects on T cell activation is crucial for developing immunomodulatory drugs.
Purpose of the Study:
- To investigate the impact of N-substituted benzamides on transcriptional regulation in Jurkat T cells.
- To assess their effects on key immune response transcription factors and gene promoters.
Main Methods:
- Jurkat T cells were stimulated via TCR/CD28 or PMA/ionomycin.
- Effects of N-substituted benzamides on NF-kappaB, NFAT, and AP-1 activity were analyzed.
- Promoter activity of CD40 ligand (CD40L) and IL-2 genes was evaluated.
Main Results:
- Acetylated N-substituted benzamides inhibited NF-kappaB and NFAT activity but enhanced AP-1 activity.
- These compounds differentially modulated CD40L and IL-2 promoter activity.
- Specific derivatives showed distinct effects on immune gene transcription.
Conclusions:
- N-substituted benzamide derivatives can quantitatively and qualitatively modulate immune functions.
- Acetylated variants show promise for targeted immune response modulation.
- These compounds represent potential therapeutic candidates for immune-related disorders.
Related Concept Videos
Co-activators and Co-repressors
Eukaryotic Transcription Inhibitors
Eukaryotic transcription inhibitors usually contain two distinct domains, a DNA...
NF-κB-dependent Signaling Pathway
NF-κB-dependent Signaling Mechanism
The heterodimer of NF-κB...
Inhibition of Cdk Activity
Inhibition of CDK Activity
Transducer Mechanism: Nuclear Receptors
About 48 different soluble family members of nuclear receptors are identified that can be divided into two main classes:

